Literature DB >> 10814618

The left ventricular dysfunction questionnaire (LVD-36): reliability, validity, and responsiveness.

C J O'Leary1, P W Jones.   

Abstract

OBJECTIVE: To examine the reliability, validity, and responsiveness of a new health status measure (LVD-36) for patients with left ventricular dysfunction which was designed with emphasis on content validity, clarity, brevity, and ease of use.
DESIGN: At baseline, patients completed the LVD-36 and a range of measures reflecting general health and disease severity. The LVD-36 was repeated after one week. After six months, it was repeated again, along with a transition question to measure global changes in health.
SETTING: Patients were recruited from the cardiology and general medical clinics at a south west London hospital. PATIENTS: 60 patients with chronic left ventricular dysfunction.
INTERVENTIONS: None. MAIN OUTCOME MEASURES: Short form 36 questionnaire (SF-36), Minnesota living with heart failure questionnaire (LIhFE), New York Heart Association criteria, and exercise performance and echocardiographic tests.
RESULTS: The LVD-36 showed good internal consistency (kappa = 0.95) and repeatability (r(i) = 0.95). Its scores were significantly associated with SF-36 mental and physical component scores (r = -0. 48 and -0.75; p < 0.0001), with exercise capacity (r = -0.52; p < 0. 0001), and with systolic shortening fraction (r = -0.27; p < 0.05). Change in the LVD-36 over six months was associated with change in overall health (F = 5.7; p < 0.001). In tests of validity and responsiveness, the LVD-36 performed similarly to or marginally better than the LIhFE.
CONCLUSIONS: The LVD-36 showed a high level of reliability and validity, and appears to measure changes in health. It provides a short, simple, valid, and reliable measure of health status in patients with left ventricular dysfunction.

Entities:  

Mesh:

Year:  2000        PMID: 10814618      PMCID: PMC1760861          DOI: 10.1136/heart.83.6.634

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  5 in total

1.  The influence of decisions made by developers on health status questionnaire content.

Authors:  C J O'Leary; P W Jones
Journal:  Qual Life Res       Date:  1998-08       Impact factor: 4.147

2.  Self-assessment of quality of life in severe heart failure. An instrument for clinical use.

Authors:  I Wiklund; K Lindvall; K Swedberg; R V Zupkis
Journal:  Scand J Psychol       Date:  1987

3.  Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale.

Authors:  L Goldman; B Hashimoto; E F Cook; A Loscalzo
Journal:  Circulation       Date:  1981-12       Impact factor: 29.690

4.  Echocardiographic measurements in normal subjects: evaluation of an adult population without clinically apparent heart disease.

Authors:  J M Gardin; W L Henry; D D Savage; J H Ware; C Burn; J S Borer
Journal:  J Clin Ultrasound       Date:  1979-12       Impact factor: 0.910

5.  Development and testing of a new measure of health status for clinical trials in heart failure.

Authors:  G H Guyatt; S Nogradi; S Halcrow; J Singer; M J Sullivan; E L Fallen
Journal:  J Gen Intern Med       Date:  1989 Mar-Apr       Impact factor: 5.128

  5 in total
  14 in total

1.  Baseline myocardial perfusion predicts response to cardiac resynchronization therapy: a prospective observational study.

Authors:  Michael V Orlov; Michael Maysky; Spyridon T Akrivakis; Michael R Ujhelyi; Peter Hoffmeister; Gunjan Shukla; Susan McAllister; Gregory Kotler; Ibrahim Almasry; G Muqtada Chaudhry; Charles I Haffajee
Journal:  J Interv Card Electrophysiol       Date:  2008-08-07       Impact factor: 1.900

2.  Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables.

Authors:  J Juenger; D Schellberg; S Kraemer; A Haunstetter; C Zugck; W Herzog; M Haass
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

3.  An evaluation of the Minnesota Living with Heart Failure Questionnaire using Rasch analysis.

Authors:  Theresa Munyombwe; Stefan Höfer; Donna Fitzsimons; David R Thompson; Deidre Lane; Karen Smith; Felicity Astin
Journal:  Qual Life Res       Date:  2014-01-12       Impact factor: 4.147

Review 4.  Oral Chinese herbal medicine for improvement of quality of life in patients with chronic heart failure: a systematic review and meta-analysis.

Authors:  Yun-Lun Li; Jian-Qing Ju; Chuan-Hua Yang; Hai-Qiang Jiang; Jing-Wen Xu; Shi-Jun Zhang
Journal:  Qual Life Res       Date:  2013-11-21       Impact factor: 4.147

5.  Disease management programme for secondary prevention of coronary heart disease and heart failure in primary care: a cluster randomised controlled trial.

Authors:  Kamlesh Khunti; Margaret Stone; Sanjoy Paul; Jan Baines; Louise Gisborne; Azhar Farooqi; Xiujie Luan; Iain Squire
Journal:  Heart       Date:  2007-02-19       Impact factor: 5.994

Review 6.  Disease-specific health-related quality of life questionnaires for heart failure: a systematic review with meta-analyses.

Authors:  Olatz Garin; Montse Ferrer; Angels Pont; Montserrat Rué; Anna Kotzeva; Ingela Wiklund; Eric Van Ganse; Jordi Alonso
Journal:  Qual Life Res       Date:  2008-12-04       Impact factor: 4.147

7.  Evidence on the global measurement model of the Minnesota Living with Heart Failure Questionnaire.

Authors:  Olatz Garin; Montse Ferrer; Àngels Pont; Ingela Wiklund; Eric Van Ganse; Gemma Vilagut; Josué Almansa; Aida Ribera; Jordi Alonso
Journal:  Qual Life Res       Date:  2013-05-16       Impact factor: 4.147

Review 8.  Assessing health-related quality of life in patients with heart failure: a systematic, standardized comparison of available measures.

Authors:  Olatz Garin; Michael Herdman; Gemma Vilagut; Montse Ferrer; Aida Ribera; Luis Rajmil; José M Valderas; Francis Guillemin; Dennis Revicki; Jordi Alonso
Journal:  Heart Fail Rev       Date:  2014-05       Impact factor: 4.214

9.  Implantable cardiac defibrillators for people with non-ischaemic cardiomyopathy.

Authors:  Mohamad El Moheb; Johny Nicolas; Assem M Khamis; Ghida Iskandarani; Elie A Akl; Marwan Refaat
Journal:  Cochrane Database Syst Rev       Date:  2018-12-08

10.  Metabolic manipulation in dilated cardiomyopathy: Assessing the role of trimetazidine.

Authors:  Suman Jatain; Aditya Kapoor; Archana Sinha; Roopali Khanna; Sudeep Kumar; Naveen Garg; Satyendra Tewari; Pravin Goel
Journal:  Indian Heart J       Date:  2016-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.